Skip to main content
OpenTrials
Completed

NCT Number: NCT00757380

Trypan Blue Versus Brillant Blue for Epiretinal Membranes

Membraneppeling alone versus Membranepeeling with Membrane Limitans Interna Pelling using two different Dyes for Epiretinal Membrane Surgery.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Idiopathic Epiretinal Membranes Epiretinal Membrane Eye Diseases Retinal Diseases

Age range

60 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery

Vienna, State of Vienna, 1030, Austria

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Idiopathic eperetinal membranes
  • Phakic or pseudophakic eyes
  • Age over 60 years

Exclusion criteria

  • Secondary epiretinal membranes
  • Severe ocular pathologies

Treatment and study plan

Trypan Blue

Procedure

Membranepeeling with TB

Brillant Blue

Procedure

Membranepeeling and membrana limitans interna peeling with BB

Primary outcomes

  1. Visual acuity

    Time frame: 3 months

Secondary outcomes

  1. Microperimetry optical coherence tomographie questionnaire (metamorphopsien)

    Time frame: 3 months

Sponsors and collaborators

Lead sponsor

The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery

Other

Registry information

Official study title

Membranepeeling With Trypan Blue Versus Membranpeeling With Brillant Blue for Patients With Idiopathic Epiretinal Membranes

Important dates

Study start
2008
Primary completion
2015
Study completion
2015
First posted
Sep 23, 2008
Registry last updated
Jan 26, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.